Clinical trials: Hypertension and Left Ventricular Hypertrophy (Thickening of the Main Pumping Chamber of the Heart)

Hypertension and Left Ventricular Hypertrophy (Thickening of the Main Pumping Chamber of the Heart)

Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (0954-133)

• Completed
• Age: 55 to 80 years
• Phase 3

The LIFE study was conducted from 1995-2001. This study was conducted in 9193 patients with high blood pressure and thickening of the main pumping chamber of the heart.

Trial name

NCT00338260

Testing

MK0954, /Duration of Treatment : 5 Years, Comparator : atenolol /Duration of Treatment : 5 Years

Volunteers

496 people

Sponsor

Organon and Co